Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

RATIONALE: Polyvinylpyrrolidone-sodium hyaluronate gel may lessen the pain of oral mucositis, or mouth sores, in patients undergoing treatment for cancer.

PURPOSE: This clinical trial is studying how well polyvinylpyrrolidone-sodium hyaluronate gel works in reducing pain from oral mucositis in young patients with cancer.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Children's Cancer and Leukaemia Group
• Treatments: Hyaluronic Acid; Povidone

Criteria

DISEASE CHARACTERISTICS:

• Diagnosis of cancer, including, but not limited to, the following:

• Acute lymphoblastic leukemia

• Acute myeloid leukemia

• Brain tumor

• Hodgkin's lymphoma

• Non-Hodgkin's lymphoma

• Sarcoma

• Wilms' tumor

• Neuroblastoma

• Meets 1 of the following criteria:

• Admitted to an in-patient unit after undergoing chemotherapy that is anticipated to cause oral mucositis

• Admitted to an in-patient unit after undergoing myeloablative therapy followed by peripheral blood stem cell or bone marrow transplantation

• Is experiencing oral pain due to mucositis

PATIENT CHARACTERISTICS:

• No known hypersensitivity to polyvinylpyrrolidone-sodium hyaluronate gel

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics

• Concurrent analgesics allowed